We are excited to announce the signing of a Memorandum of Understanding between Biointelect and Health Security Systems Australia (HSSA), a division of DMTC, to strengthen collaboration in support of Australia’s health security and innovation ecosystem.
This partnership is particularly timely as the Australian Vaccine Value Chain Conference (#AVVCC26) takes place in Sydney this week, with collaboration and partnerships at the heart of strengthening the vaccine value chain. Biointelect and HSSA bring complementary expertise in health innovation, commercialisation, capability development and national health security to help accelerate the translation of promising technologies into real-world impact.
For Biointelect, through Biointelect Venturer, this collaboration strengthens our role in bridging the gap between scientific discovery and successful commercial outcomes by connecting infectious disease innovators with broader networks, expertise and pathways to translation.
We look forward to exploring opportunities that strengthen Australia’s preparedness, resilience and sovereign capability in the face of current and emerging health threats.
Thank you to our colleagues at HSSA and DMTC for their collaboration and shared commitment to advancing Australia’s health security future.
Read the press release here
